“Baseline Characteristics in Patients With Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy)”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s734. https://doi.org/10.25251/djee0862.